Literature DB >> 19319638

Treatment of arteriovenous shunts after renal transplantation.

Hidehisa Kitada1, Atsushi Sugitani, Yasuhiro Okabe, Atsushi Doi, Yasunobu Nishioka, Takehiro Nishiki, Tadashi Kayashima, Reiko Tanabe, Masao Tanaka.   

Abstract

PURPOSE: Immunosuppressive drugs have improved the results of renal transplantation dramatically in recent years; however, there is still no consensus on the treatment of arteriovenous (A-V) shunts after successful transplantation. We evaluated the treatment of A-V shunts after transplantation.
METHODS: We reviewed all patients who underwent shunt closure at our hospital between 2005 and 2007 assessing surgical methods, operative time, blood loss, and complications.
RESULTS: Fifty-two patients underwent shunt closure, as a simple transection in 5 patients, resection of the anastomotic site in 16, resection and reconstruction of the artery in 26, and graftectomy in 5. Graftectomy was associated with copious blood loss and a long operative time. The most frequent complication was phlebitis, but there were no nerve complications.
CONCLUSIONS: An A-V shunt after renal transplantation may result in an aneurysm, severe venous dilatation, pain, bloating of the arm, infection, and cardiac problems. Thus, after successful transplantation, shunt closure should be performed to prevent these complications and to improve quality of life.

Entities:  

Mesh:

Year:  2009        PMID: 19319638     DOI: 10.1007/s00595-008-3897-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Effects of arteriovenous fistulas on cardiac oxygen supply and demand.

Authors:  W J Bos; R Zietse; K H Wesseling; N Westerhof
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

2.  Complications of arteriovenous fistulas for hemodialysis.

Authors:  M Haimov; A Baez; M Neff; R Slifkin
Journal:  Arch Surg       Date:  1975-06

3.  The relation between vascular access flow and different types of vascular access with systemic hemodynamics in hemodialysis patients.

Authors:  Edwin Wijnen; Xavier H Keuter; Nils R Planken; Frank M van der Sande; Jan H Tordoir; Karel M Leunissen; Jeroen P Kooman
Journal:  Artif Organs       Date:  2005-12       Impact factor: 3.094

4.  Heart failure as a complication of hemodialysis arteriovenous fistula.

Authors:  D J Ahearn; J F Maher
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

Review 5.  Infectious complications of the hemodialysis access.

Authors:  G M Nassar; J C Ayus
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

Review 6.  Do AV fistulas contribute to cardiac mortality in hemodialysis patients?

Authors:  Ralf Dikow; Vedat Schwenger; Martin Zeier; Eberhard Ritz
Journal:  Semin Dial       Date:  2002 Jan-Feb       Impact factor: 3.455

7.  Management and outcome of living kidney grafts with multiple arteries.

Authors:  Yayoi Kadotani; Masahiko Okamoto; Kiyokazu Akioka; Hidetaka Ushigome; Shiro Ogino; Shuji Nobori; Atsushi Higuchi; Yoshihiro Wakabayashi; Satoshi Kaihara; Norio Yoshimura
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan.

Authors:  Takao Sonoda; Shiro Takahara; Kota Takahashi; Kazuharu Uchida; Shinichi Ohshima; Hiroshi Toma; Kazunari Tanabe; Norio Yoshimura
Journal:  Transplantation       Date:  2003-01-27       Impact factor: 4.939

9.  The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients.

Authors:  Carlo Basile; Carlo Lomonte; Luigi Vernaglione; Francesco Casucci; Maurizio Antonelli; Nicola Losurdo
Journal:  Nephrol Dial Transplant       Date:  2007-10-17       Impact factor: 5.992

10.  Banding a hemodialysis arteriovenous fistula to decrease blood flow and resolve high output cardiac failure: report of a case.

Authors:  S Isoda; H Kajiwara; J Kondo; A Matsumoto
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.